California wildfires pose lung health risk to first responders, people with chronic lung diseases


Smoke and toxic air pollutants increase lung inflammation

Miami (January 16, 2025) - Wildfire smoke and the resulting air pollutants from burning debris and chemicals can result in significant lung health risks for those exposed, particularly people with chronic lung diseases including chronic obstructive lung disease (COPD), and first responders on the front line.

Wildfire smoke is a mixture of gases and fine, microscopic particles. These particles can cause burning eyes, a runny nose and difficulty breathing. People with COPD and other chronic lung diseases can also experience increased exacerbations (or flare-ups) of their symptoms when breathing this toxic air.

COPD is an inflammatory lung disease, comprising several conditions, including chronic bronchitis and emphysema, and can be caused by genetics and irritants like smoke and pollution. The disease affects more than 30 million Americans and is the fourth leading cause of death worldwide.

Exposure to wildfire smoke can cause wheezing, shortness of breath, persistent cough, chest heaviness and difficulty breathing. People experiencing these symptoms should seek immediate medical attention. People with COPD should continue to take their medications and follow their health care providers' directions on managing their disease.

"The wildfires in California have caused widespread devastation and will continue to pose significant risks to respiratory health long after they are extinguished, particularly for those with pre-existing conditions," said Jean Wright, M.D., MBA, CEO of the COPD Foundation. "These risks will persist even after the fires are extinguished. We urge everyone to take the necessary steps to protect their lungs."

For more information on protecting your lung health during and after wildfires, visit www.cdc.gov/wildfires/risk-factors.

###

About the COPD Foundation
The COPD Foundation is a nonprofit organization whose mission is to help millions of people live longer and healthier lives by advancing research, advocacy, and awareness to stop COPD, bronchiectasis, and NTM lung disease. The Foundation does this through scientific research, education, advocacy, and awareness to prevent disease, slow progression, and find a cure. For more information, visit copdfoundation.org, or follow us on Twitter and LinkedIn.

Contact:
Brittany Irish
805-465-2497
mediarelations@copdfoundation.org